JP Morgan Maintains Overweight on Zoetis, Lowers Price Target to $130

Benzinga Newsdesk www.benzinga.com Negative 79.5%

Neg 79.5% Neu 0% Pos 0%

JP Morgan analyst Chris Schott maintains Zoetis (NYSE:ZTS) with a Overweight and lowers the price target from $190 to $130.